Novartis Settles Criminal, Qui Tam Cases For $422.5M
Novartis Pharmaceuticals Corp. has agreed to shell out $237.5 million to settle civil allegations that it promoted the epilepsy drug Trileptal for off-label uses and paid kickbacks to get doctors to...To view the full article, register now.
Already a subscriber? Click here to view full article